CYTOSORBENTS CORPORATION Restructuring Reserve, Current
CYTOSORBENTS CORPORATION (CTSO) had Restructuring Reserve, Current of $65.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:RestructuringReserveCurrent · last filed 2026-08-06
- 2026-06-30: Restructuring Reserve, Current $65.00K.
- 2026-03-31: Restructuring Reserve, Current $128.00K.
- 2025-12-31: Restructuring Reserve, Current $297.00K.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2026-06-30 | $65.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $128.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $297.00K 10-Q · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |